Dr. Kaklamani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
7979 Wurzbach Road
San Antonio, TX 78229Phone+1 210-450-1143Fax+1 210-450-0407- Is this information wrong?
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2000 - 2003
- Newton-Wellesley HospitalResidency, Internal Medicine, 1997 - 2000
- University of AthensClass of 1996
Certifications & Licensure
- TX State Medical License 2014 - 2025
- IL State Medical License 2000 - 2017
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer Start of enrollment: 2002 Jul 01
- Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Start of enrollment: 2006 May 04
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Join now to see all
Publications & Presentations
PubMed
- 36 citationsEMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancerAditya Bardia, Philippe Aftimos, Teeru Bihani, Alfred T Anderson-Villaluz, JungAh Jung
Future Oncology. 2019-08-20 - 398 citationsGenome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's diseaseElaine F. Remmers, Fulya Cosan, Yohei Kirino, Michael J. Ombrello, Neslihan Abaci
Nature Genetics. 2010-08-01 - 942 citationsProspective Validation of a 21-Gene Expression Assay in Breast CancerJoseph A. Sparano, Robert Gray, D. F. Makower, Kathleen I. Pritchard, Kathy S. Albain
The New England Journal of Medicine. 2015-11-18
Lectures
- Genomic stratification with BCI of ER+ early breast cancer patients with limited long-term risk of breast cancer death.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Other
- Axillary node metastases with occult primary breast cancerKaklamani V, Gradishar WJ
http://www.uptodate.com/contents/axillary-node-metastases-with-occult-primary-breast-cancer
UpToDate, Wolters Kluwer Health - 2012-08-07
Press Mentions
- Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023May 26th, 2023
- New Recommendations in Place for Breast Cancer ScreeningsMay 15th, 2023
- 3 Things You Didn’t Know to Ask Your Doctor —Until NowMay 4th, 2023
- Join now to see all
Professional Memberships
- Member
Other Languages
- Greek
Hospital Affiliations
- University Health / UT Health Science Center at San AntonioSan Antonio, Texas
- CHRISTUS Santa Rosa Health SystemSan Antonio, Texas
- St Lukes Baptist HospitalSan Antonio, Texas
- University Health / UT Health Science Center at San AntonioSan Antonio, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: